Cipla Share Price: Citi bullish on Pharma stock; gives ‘BUY’ call, cites boost in complex generic credibility – Check target – Markets

Founded in 1935, Cipla has a major presence across India, South Africa, and North America. The company has 46 advanced manufacturing hubs, producing over 1,500 products. Its key segments span across respiratory, anti-retroviral and cardiology. Recognised for its role in making HIV/AIDS treatment affordable and inclusive, Cipla has a market cap of over Rs 1 lakh crore.